Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

86
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
86
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

79
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
79
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

67
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
67
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

242
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
242
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

461
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
461

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same author

Sexual transmission of vaginal pathogens and male partner treatment: is it time to consider vulvovaginal candidiasis?

Sexually transmitted infections·2026
Same author

State-of-the-Art Review: Managing Vulvovaginal Candidiasis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Partner treatment in women with bacterial vaginosis: an update to the International Society for the Study of Vulvovaginal Disease (ISSVD) recommendations.

Sexually transmitted infections·2026
Same author

Elevated vaginal heparan sulfate correlates with impaired neutrophil killing of <i>Candida albicans</i> in women with vulvovaginal candidiasis.

Infection and immunity·2026
Same author

Methodologic and analytic considerations in the CANDLE trial of ibrexafungerp for recurrent vulvovaginal candidiasis (reply to letter to the editor).

American journal of obstetrics and gynecology·2026
Same journal

Diagnostic Accuracy of MiRNA Panels for Endometrial Cancer: A Systematic Review and Meta-Analysis.

Journal of lower genital tract disease·2026
Same journal

Diagnostic Strategies After Negative Colposcopy in High-Grade Cervical Cytology: A Multicenter Randomized Trial.

Journal of lower genital tract disease·2026
Same journal

Bacterial and Fungal Profiles in Mixed Vaginitis Versus Bacterial Vaginosis.

Journal of lower genital tract disease·2026
Same journal

ASCCP President 's Message.

Journal of lower genital tract disease·2026
Same journal

Human Papillomavirus Test Agreement Between Self-Collected Vaginal and Clinician-Collected Cervical Specimens.

Journal of lower genital tract disease·2026
Same journal

Awards presented as part of the ASCCP 2026 Scientific Meeting on Anogenital & HPV-Related Diseases.

Journal of lower genital tract disease·2026
See all related articles

Related Experiment Video

Updated: Oct 9, 2025

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

2.6K

Lower Genital Tract Microbiome-A Work in Progress.

Jack D Sobel1

  • 1Wayne State University School of Medicine, Detroit, MI.

Journal of Lower Genital Tract Disease
|December 20, 2021
PubMed
Summary
This summary is machine-generated.

The lower genital tract microbiome, influenced by various factors, is increasingly understood through advanced research. This knowledge is being translated to improve clinical diagnosis, prognosis, and treatment of related diseases.

More Related Videos

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

6.4K
Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization
12:37

Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization

Published on: April 14, 2016

39.1K

Related Experiment Videos

Last Updated: Oct 9, 2025

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

2.6K
Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

6.4K
Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization
12:37

Efficient Nucleic Acid Extraction and 16S rRNA Gene Sequencing for Bacterial Community Characterization

Published on: April 14, 2016

39.1K

Area of Science:

  • Gynecology
  • Microbiology
  • Clinical Science

Background:

  • The lower genital tract harbors a complex microbiome influenced by genetic, biologic, and behavioral factors.
  • Advances in technology have significantly expanded our understanding of this microbial ecosystem over the past decade.
  • There is a gap between scientific discoveries in vaginal microbiota and their application by clinical practitioners.

Purpose of the Study:

  • To bridge the gap between vaginal microbiota science and clinical practice.
  • To present the clinical application of recent molecular findings in diagnosing, prognosticating, and treating lower genital tract diseases.
  • To highlight opportunities for managing vulvovaginal diseases by understanding microbiota dynamics.

Main Methods:

  • Review and synthesis of recent molecular laboratory findings.
  • Clinical application of scientific research on vaginal microbiota.
  • Identification of diagnostic, prognostic, and therapeutic advances.

Main Results:

  • Recent molecular findings have been translated into clinical applications for lower genital tract diseases.
  • Understanding the dynamism of the vaginal microbiota enhances the understanding of disease pathogenesis.
  • Opportunities for improved vulvovaginal disease management have been identified.

Conclusions:

  • Translating advances in vaginal microbiota science into clinical practice is crucial for improving patient care.
  • The dynamic nature of the vaginal microbiome is key to understanding and managing lower genital tract diseases.
  • Further integration of research findings can lead to significant diagnostic, prognostic, and therapeutic progress.